Financhill
Back

Rhythm Pharmaceuticals Quote, Financials, Valuation and Earnings

9,530x the last time this happened

Here's what our expert says you should buy before April 14.
Buy
56

RYTM
Rhythm Pharmaceuticals

Last Price:
39.79
Seasonality Move:
13.39%

7 Day Trial

ALL ACCESS PASS

$ 7

My #1 Coin is...

All the details are on the next page.

Rhythm Pharmaceuticals Price Quote

$39.79
-0.01 (2.5%)
(Updated: May 1, 2024 at 6:17 AM ET)

Rhythm Pharmaceuticals Key Stats

Buy
56
Rhythm Pharmaceuticals (RYTM) is a Buy

Day range:
$37.60 - $41.27
52-week range:
$15.50 - $52.57
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
29.64
P/B ratio:
14.3%

Volume:
503.1K
Avg. volume:
519.4K
1-year change:
97.32%
Market cap:
$2.4B
Revenue:
$77.4M
EPS:
$-3.2

How Much Does Rhythm Pharmaceuticals Make?

Is Rhythm Pharmaceuticals Growing As A Company?

Rhythm Pharmaceuticals Stock Price Performance

What Is Rhythm Pharmaceuticals 52-Week High & Low?

Rhythm Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Rhythm Pharmaceuticals?

Is Rhythm Pharmaceuticals Cash Flow Positive?

  • What Is RYTM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$136.2M
  • What Is Rhythm Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $74.4M
  • What Is Rhythm Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$5.7M

Rhythm Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    RYTM return on invested capital is -89.34%
  • What Is Rhythm Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -53.53%
  • What Is RYTM Return On Equity?
    ROE is a measure of profitability and is -89.34%

Rhythm Pharmaceuticals Earnings Date & Stock Price

Rhythm Pharmaceuticals Competitors

Rhythm Pharmaceuticals Dividend Yield

Data Unavailable

Rhythm Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0.94%
Revenue: 175.7% -4.52%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 57.33
Upside from Last Price: 44.05%

Major Shareholders

  • How many RYTM shares are owned by institutional investors?
    111.7M RYTM shares are owned by institutional investors
  • How many RYTM shares are owned by insiders?
    1.1M RYTM shares are owned by insiders